Longitudinal Observational Study on Immune Thrombocytopenia

Not yet recruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

July 10, 2025

Primary Completion Date

December 31, 2035

Study Completion Date

December 31, 2036

Conditions
Immune Thrombocytopenia (ITP)
Trial Locations (1)

Unknown

Peking University Insititute of Hematology, Peking University People's Hospital, Beijing, Beijing 100010, Beijing

All Listed Sponsors
collaborator

Jiangsu Provincial People's Hospital

OTHER

collaborator

Wuhan TongJi Hospital

OTHER

lead

Peking University People's Hospital

OTHER